Clinical Trials Logo
  1. Home
  2. Autoimmune Disease
  3. NCT03715699

Leflunomide Treatment for IgG4-RD

Autoimmune Disease Clinical Trial

Official title:
Leflunomide Treatment for IgG4-RD

Clinical Trial Summary

This study is an open-label randomized controlled trial aiming to investigate whether the efficacy and side effect of Leflunpomide plus glucocorticoid.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03715699
Study type Interventional
Source Peking Union Medical College Hospital
Contact Yunyun FEI
Phone +8613681125226
Email feiyunyun2013@hotmail.com
Status Recruiting
Phase N/A
Start date July 1, 2018
Completion date December 31, 2020
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01934764 - Identification of Correlations Between Reaction to Biotine and Autoimmune Diseases N/A
Recruiting NCT01665196 - 18F-FDG PET/CT for IgG4-Related Disease Early Phase 1
Withdrawn NCT02948855 - Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases
Completed NCT01815996 - Identify Clinical Conditions That Increase Circulating DNA Levels
Completed NCT02434458 - Sudoscan in Patients With Autoimmune Disorders N/A
Completed NCT02263703 - Immunogenicity of HPV Vaccine in Immunosuppressed Children Phase 3
Completed NCT00013689 - Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome Phase 1
Completed NCT00340600 - Continuation of Follow-up of DES-Exposed Cohorts
Not yet recruiting NCT05894707 - Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers Phase 1
Completed NCT02647866 - Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis Phase 2
Active, not recruiting NCT00716066 - Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases Phase 2
Completed NCT00351377 - Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate Phase 3
Completed NCT00114530 - Scleroderma: Cyclophosphamide or Transplantation Phase 2/Phase 3
Completed NCT00001630 - Treatment of Autoimmune Thrombocytopenia (AITP) Phase 1
Completed NCT00372177 - The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis Phase 1/Phase 2
Completed NCT00065390 - Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome Phase 1
Completed NCT00001658 - Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections Phase 4
Recruiting NCT03816345 - Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer Phase 1
Completed NCT00001306 - Steroid Therapy in Autoimmune Premature Ovarian Failure N/A
Completed NCT02925351 - Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases Early Phase 1